The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

AC1L3GW5     (1S,6R,8R,9R)-8-(6-amino-8- azido-purin-9...

Synonyms: 31966-52-6, 8-Azido-cyclic AMP, 8-Azidoadenosine-3',5'-monophosphate, 8-Azidoadenosine 3',5'-monophosphate
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of 8-N3-cAMP

  • Incubation of H-35 hepatoma cells with vesicle-8-N3-cAMP resulted in increased TAT activity, preceded by the binding of 8-N3-cAMP to the regulatory subunit of type II cAMP-dependent protein kinase [1].
 

High impact information on 8-N3-cAMP

  • Although the average incorporation of 8-N3-cAMP was 0.29 +/- 0.02 (S.E.) pmol/mg protein for control and 0.45 +/- 0.06 pmol/mg protein for neoplastic breast tissue cytosol, this difference does not reflect different cellular concentrations of cAMP receptors since the content of blood protein components is lower in tumor tissue [2].
  • Because it can be presumed that protein phosphorylation regulates the functioning of ion channel proteins, we have characterized cAMP-binding proteins photoaffinity labeled with 8-N3-cAMP and have found that, unlike other tissues, the nervous system contains a great variety of binding species [3].
  • A stoichiometry of 1 mol of 8-N3-cAMP incorporated per R-monomer was observed for each mutant regulatory subunit as well, even when 2 mol of 8-N3-cAMP were bound per R-monomer; however, the major sites of covalent modification were altered as follows: R(Y371/W), Trp-371; R(E200/D), Tyr-371, and R(F247/Y), Tyr-371 [4].
  • Protein kinase I in macrophages demonstrated higher affinity for 8-N3-cAMP (KD = 0.7 nM) than did protein kinase II from either monocytes (KD = 14.5 nM) or macrophages (KD = 4.9 nM) [5].
  • Moreover, exposure of T lymphocytes to the cyclic nucleotide derivatives 8-N3-cAMP and 8-Br-cAMP mimicked the effect of adenosine, significantly reducing the time to half-maximal capping [6].
 

Biological context of 8-N3-cAMP

  • Activation of protein kinase isoenzymes under near physiological conditions. Evidence that both types (A and B) of cAMP binding sites are involved in the activation of protein kinase by cAMP and 8-N3-cAMP [7].
  • The data indicate that the regulatory subunit contains an ATP regulatory site which inhibits 8-N3 cAMP binding and the release of the catalytic subunit [8].
 

Anatomical context of 8-N3-cAMP

 

Associations of 8-N3-cAMP with other chemical compounds

  • (3) Both native polyacrylamide gel electrophoresis as well as photoaffinity labeling with 8-azido-cyclic AMP demonstrate marked increases in type l cyclic AMP-dPK in the cytosols of cells exposed to agents that induce myeloid differentiation but no increase in TPA-differentiated cells [13].
  • Activation of adenylate cyclase, inhibition of cAMP-dependent phosphodiesterase, or the direct addition of the cell-permeable cAMP analog, 8-N3-cAMP, increased occupancy of intracellular cAMP receptors, inhibited IL-2 production, and reduced T-cell proliferation [14].
 

Gene context of 8-N3-cAMP

  • First cyclic AMP and adenosine each blocked binding of both radioactively labelled 8-N3-Ado and 8-N3-cAMP, and second, digestion with V8 proteinase generated identical patterns of peptides from AdoHcyase that had been photolabelled with [32P]8-N3-cAMP and [3H]8-N3-Ado [15].
  • Using 8-N3-cAMP photoaffinity labeling, normal and transformed cells were also found to contain equal quantities of a single 42,000 Mr regulatory sub-unit isoenzyme of A-kinase [16].

References

  1. Induction of tyrosine aminotransferase in H-35 hepatoma cells by cAMP captured in phospholipid vesicles. Culpepper, J.A., Liu, A.Y. J. Cell Biol. (1981) [Pubmed]
  2. Cyclic adenosine 3':5'-monophosphate receptor proteins in dysplastic and neoplastic human breast tissue cytosol and their inverse relationship with estrogen receptors. Handschin, J.C., Handloser, K., Takahashi, A., Eppenberger, U. Cancer Res. (1983) [Pubmed]
  3. Characterization and localization of adenosine 3':5'-monophosphate-binding proteins in the nervous system of Aplysia. Eppler, C.M., Palazzolo, M.J., Schwartz, J.H. J. Neurosci. (1982) [Pubmed]
  4. Effects of cAMP-binding site mutations on intradomain cross-communication in the regulatory subunit of cAMP-dependent protein kinase I. Ringheim, G.E., Taylor, S.S. J. Biol. Chem. (1990) [Pubmed]
  5. Induction of cAMP-dependent protein kinase I during human monocyte differentiation. Wenger, G.D., O'Dorisio, M.S. J. Immunol. (1985) [Pubmed]
  6. Regulation of human T lymphocyte surface antigen mobility by purinergic receptors. Kammer, G.M., Rudolph, S.A. J. Immunol. (1984) [Pubmed]
  7. Activation of protein kinase isoenzymes under near physiological conditions. Evidence that both types (A and B) of cAMP binding sites are involved in the activation of protein kinase by cAMP and 8-N3-cAMP. Ogreid, D., Døskeland, S.O. FEBS Lett. (1982) [Pubmed]
  8. Use of photoaffinity nucleotide analogs to determine the mechanism of ATP regulation of a membrane-bound, cAMP-activated protein kinase. Owens, J.R., Haley, B.E. J. Supramol. Struct. (1978) [Pubmed]
  9. Cyclic AMP-dependent protein kinases from Balb 3T3 cells and other 3T3 derived lines. Wehner, J.M., Malkinson, A.M., Wiser, M.F., Sheppard, J.R. J. Cell. Physiol. (1981) [Pubmed]
  10. A study of cAMP binding proteins on intact and disrupted sperm cells using 8-azidoadenosine 3',5'-cyclic monophosphate. Schoff, P.K., Forrester, I.T., Haley, B.E., Atherton, R.W. J. Cell. Biochem. (1982) [Pubmed]
  11. Phosphorylation of type II cAMP-dependent protein kinase in renal brush border membranes. Hammerman, M.R. Am. J. Physiol. (1986) [Pubmed]
  12. The labeling with 8-azido-cyclic adenosine monophosphate of proteins in vesicles of sarcoplasmic reticulum from rabbit skeletal muscle. Lord, S.T., Richards, F.M. Biochim. Biophys. Acta (1981) [Pubmed]
  13. Cyclic AMP-dependent and -independent protein kinases and protein phosphorylation in human promyelocytic leukemia (HL60) cells induced to differentiate by retinoic acid. Fontana, J.A., Emler, C., Ku, K., McClung, J.K., Butcher, F.R., Durham, J.P. J. Cell. Physiol. (1984) [Pubmed]
  14. Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway. Averill, L.E., Stein, R.L., Kammer, G.M. Cell. Immunol. (1988) [Pubmed]
  15. Covalent labelling of ligand binding sites of human placental S-adenosylhomocysteine hydrolase with 8-azido derivatives of adenosine and cyclic AMP. Aiyar, V.N., Hershfield, M.S. Biochem. J. (1985) [Pubmed]
  16. Comparison of cAMP-dependent protein kinase in normal and Rous sarcoma virus transformed chick embryo fibroblasts. Kudlow, J.E., Watson, R.K., Gill, G.N. Journal of cyclic nucleotide research. (1981) [Pubmed]
 
WikiGenes - Universities